Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...
Inside the growing scientific quest to understand what creatures with the extraordinary ability to defy the ravages of time ...
Colossal Biosciences’ CEO says its work follows a ‘moral obligation’ while critics say it’s ‘tech bro’ hype that could undermine conservation ...
A silent revolution is unfolding inside Indian laboratories. From the patent-free power of an indigenous CRISPR tool to ...
Spread the loveIn a significant breakthrough for plant genomics, researchers at Cold Spring Harbor Laboratory, alongside international collaborators, have unveiled a treasure trove of ancient ...
Explore the differences between BTech Bioengineering and BSBE in 2026. Compare core subjects, laboratory focus, and career ...
Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...
UK agbiotech Tropic raises $105m to scale gene-edited non-browning and extended shelf-life bananas, and advance TR4-resistant varieties.
Organizaciones instan a participar en consulta pública sobre nuevas técnicas genéticas y trigo editado Warnings are issued regarding ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...
Key opportunities in Saudi Arabia's synthetic biology market include leveraging government investments and biotechnology advancements driven by Vision 2030. The focus is on reducing oil dependence by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results